Aura Biosciences, Inc. (AURA) NASDAQ
6.90
-0.29(-4.03%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
6.90
-0.29(-4.03%)
Currency In USD
| Market Cap | 328.84M |
| Enterprise Value | 286.7M |
| P/E Ratio | -4.14 |
| PEG Ratio | -0.61 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.34 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.24 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.82 |
| Return On Equity | -0.78 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -111.66M |
| Net Income | -106.19M |
| Diluted EPS | -1.76 |
| Total Cash | 114.73M |
| Total Cash/Share | 1.7 |
| Total Debt | 16.99M |
| Total Debt/Equity | 0.16 |
| Current Ratio | 7.09 |
| Book Value Per Share | 1.59 |
| 52-Week Change | 9 |
| 52-Week High | 9.54 |
| 52-Week Low | 4.73 |
| Moving Average 50 Days | 7.25 |
| Moving Average 200 Days | 6.25 |
| Average Volume | 478,738 |
| Shares Outstanding | 64.2M |
| % Held by Institutions | 84.33 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |